Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women
AUTOR(ES)
Patterson, Bruce K.
FONTE
American Society for Clinical Investigation
RESUMO
The placenta may play a critical role in inhibiting vertical transmission of HIV-1. Here we demonstrate that leukemia inhibitory factor (LIF) is a potent endogenous HIV-1–suppressive factor produced locally in placentae. In vitro, LIF exerted a potent, gp130-LIFRβ–dependent, HIV coreceptor–independent inhibition of HIV-1 replication with IC50 values between 0.1 pg/ml and 0.7 pg/ml, depending on the HIV-1 isolate. LIF also inhibited HIV-1 in placenta and thymus tissues grown in ex vivo organ culture. The level of LIF mRNA and the incidence of LIF protein–expressing cells were significantly greater in placentae from HIV-1–infected women who did not transmit HIV-1 to their fetuses compared with women who transmitted the infection, but they were not significantly different from placentae of uninfected mothers. These findings demonstrate a novel pathway for endogenous HIV suppression that may prove to be an effective immune therapy for HIV infection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=199198Documentos Relacionados
- Urokinase–urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication
- Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes
- Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
- HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation
- A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.
